Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine Use in Suprazygomatic Maxillary Nerve Blocks for Pediatric Adenotonsillectomy Pain Control

NCT05208892 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05208892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05208892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine Use in Suprazygomatic Maxillary Nerve Blocks for Pediatric Adenotonsillectomy Pain Control
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
January 29, 2024
Completion date
December 31, 2025
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use, postoperative pain